What happened with Novo Nordisk stock? On Dec. 20, Novo announced results from a phase 3 clinical trial surrounding one of ...

Two new studies suggest that the diabetes medication Ozempic may double the risk of a rare but serious condition that damages ...

The agency’s main drug review office cleared 50 novel medicines last year, short of 2018’s record total but on the higher end ...

The rest of Europe could learn from them. Politicians in Brussels are perpetually searching for ways to invigorate the ...

Here are some clinical trials that could send Big Pharma shares soaring, or crashing, in 2025. Eli Lilly. The world’s biggest ...

Following billionaire investors isn't as difficult as you might imagine thanks to quarterly reporting required by the ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

The story of Eli Lilly and Novo Nordisk’s GLP-1 dominance is likely to play out again in 2025 as the metabolic medicine ...

Trump could keep Biden’s commitment to have Medicare pay for weight loss drugs such as Ozempic and Wegovy. But would ...

Whether this year’s big job commitments sink or swim will be known in time. But for now, let’s explore the dreams.

A new technology is disrupting the economy. Even experts don’t entirely understand how it works, its full range of uses and ...

In a citizen petition posted by the FDA this week, Novo urged the regulator to restrict the ability of compounding pharmacies to produce Victoza, also known as liraglutide, following a proposal by the ...